UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 709

Sortiert nach

Pharmacological characterization of potent and selective NaV1.7 inhibitors engineered from Chilobrachys jingzhao tarantula venom peptide JzTx-V

PloS one, 2018-05, Vol.13 (5), p.e0196791-e0196791

2018

Link zum Volltext

Verfügbarkeit prüfen

Molecular Mechanism of Hepcidin-Mediated Ferroportin Internalization Requires Ferroportin Lysines, Not Tyrosines or JAK-STAT

Cell metabolism, 2012-06, Vol.15 (6), p.905-917

2012

Link zum Volltext

Verfügbarkeit prüfen

Epitope Discovery for a Synthetic Polymer Nanoparticle: A New Strategy for Developing a Peptide Tag

Journal of the American Chemical Society, 2014-01, Vol.136 (4), p.1194-1197

2014

Link zum Volltext

Verfügbarkeit prüfen

Development of human-machine language interfaces for the visual analysis of complex biologics and RNA modalities and associated experimental data

AAPS open, 2023-03, Vol.9 (1), p.5-11, Article 5

2023

Link zum Volltext

Verfügbarkeit prüfen

Utilization of tyrosine- and histidine-containing dipeptides to enhance productivity and culture viability

Biotechnology and bioengineering, 2012-09, Vol.109 (9), p.2286-2294

2012

Link zum Volltext

Verfügbarkeit prüfen

Identification of Antibody and Small Molecule Antagonists of Ferroportin-Hepcidin Interaction

Frontiers in pharmacology, 2017-11, Vol.8, p.838-838

2017

Link zum Volltext

Verfügbarkeit prüfen

Structure-guided Discovery of Dual-recognition Chemibodies

Scientific reports, 2018-05, Vol.8 (1), p.7570-9, Article 7570

2018

Link zum Volltext

Verfügbarkeit prüfen

Development of a method for the sensitive and quantitative determination of hepcidin in human serum using LC-MS/MS

Journal of pharmacological and toxicological methods, 2009-05, Vol.59 (3), p.171-180

2009

Link zum Volltext

Verfügbarkeit prüfen

Design and Chemical Synthesis of a Homogeneous Polymer-Modified Erythropoiesis Protein

Science (American Association for the Advancement of Science), 2003-02, Vol.299 (5608), p.884-887

2003

Link zum Volltext

Verfügbarkeit prüfen

Probing the S100 protein family through genomic and functional analysis

Genomics (San Diego, Calif.), 2004-07, Vol.84 (1), p.10-22

2004

Link zum Volltext

Verfügbarkeit prüfen

Engineering Potent and Selective Analogues of GpTx-1, a Tarantula Venom Peptide Antagonist of the NaV1.7 Sodium Channel

Journal of medicinal chemistry, 2015-03, Vol.58 (5), p.2299-2314

2015

Link zum Volltext

Verfügbarkeit prüfen

Engineering potent and selective analogues of GpTx-1, a tarantula venom peptide antagonist of the Na(V)1.7 sodium channel

Journal of medicinal chemistry, 2015-03, Vol.58 (5), p.2299-2314

2015

Link zum Volltext

Verfügbarkeit prüfen

Single Residue Substitutions That Confer Voltage-Gated Sodium Ion Channel Subtype Selectivity in the NaV1.7 Inhibitory Peptide GpTx‑1

Journal of medicinal chemistry, 2016-03, Vol.59 (6), p.2704-2717

2016

Link zum Volltext

Verfügbarkeit prüfen

Accelerating attribute‐focused process and product development through the development and deployment of autonomous process analytical technology platform system

Biotechnology and bioengineering, 2024-04, Vol.121 (4), p.1257-1270

2024

Link zum Volltext

Verfügbarkeit prüfen

Nanoscale integration of single cell biologics discovery processes using optofluidic manipulation and monitoring

Biotechnology and bioengineering, 2019-09, Vol.116 (9), p.2393-2411

2019

Link zum Volltext

Verfügbarkeit prüfen

Discovery of Tarantula Venom-Derived NaV1.7-Inhibitory JzTx‑V Peptide 5‑Br-Trp24 Analogue AM-6120 with Systemic Block of Histamine-Induced Pruritis

Journal of medicinal chemistry, 2018-11, Vol.61 (21), p.9500-9512

2018

Link zum Volltext

Verfügbarkeit prüfen

Discovery of Selective Pituitary Adenylate Cyclase 1 Receptor (PAC1R) Antagonist Peptides Potent in a Maxadilan/PACAP38-Induced Increase in Blood Flow Pharmacodynamic Model

Journal of medicinal chemistry, 2021-03, Vol.64 (6), p.3427-3438

2021

Link zum Volltext

Verfügbarkeit prüfen

Half-life extension of peptidic APJ agonists by N-terminal lipid conjugation

Bioorganic & medicinal chemistry letters, 2020-11, Vol.30 (21), p.127499-127499, Article 127499

2020

Link zum Volltext

Verfügbarkeit prüfen

Accelerated Chemical Synthesis of Peptides and Small Proteins

Proceedings of the National Academy of Sciences - PNAS, 1999-02, Vol.96 (4), p.1181-1186

1999

Link zum Volltext

Verfügbarkeit prüfen

Pharmaceutical Optimization of Peptide Toxins for Ion Channel Targets: Potent, Selective, and Long-Lived Antagonists of Kv1.3

Journal of medicinal chemistry, 2015-09, Vol.58 (17), p.6784-6802

2015

Link zum Volltext

Verfügbarkeit prüfen

Use of Cryopreserved Hepatocytes as Part of an Integrated Strategy to Characterize In Vivo Clearance for Peptide-Antibody Conjugate Inhibitors of Nav1.7 in Preclinical Species

Drug metabolism and disposition, 2019-10, Vol.47 (10), p.1111-1121

2019

Link zum Volltext

Verfügbarkeit prüfen

Sustained inhibition of the NaV1.7 sodium channel by engineered dimers of the domain II binding peptide GpTx-1

Bioorganic & medicinal chemistry letters, 2015-11, Vol.25 (21), p.4866-4871

2015

Link zum Volltext

Verfügbarkeit prüfen

Discovery of Tarantula Venom-Derived Na V 1.7-Inhibitory JzTx-V Peptide 5-Br-Trp24 Analogue AM-6120 with Systemic Block of Histamine-Induced Pruritis

Journal of medicinal chemistry, 2018-11, Vol.61 (21), p.9500-9512

2018

Link zum Volltext

Verfügbarkeit prüfen

Engineering Antibody Reactivity for Efficient Derivatization to Generate NaV1.7 Inhibitory GpTx‑1 Peptide–Antibody Conjugates

ACS chemical biology, 2017-09, Vol.12 (9), p.2427-2435

2017

Link zum Volltext

Verfügbarkeit prüfen

Design and Synthesis of Conformationally Constrained Glucagon-Like Peptide-1 Derivatives with Increased Plasma Stability and Prolonged in Vivo Activity

Journal of medicinal chemistry, 2008-05, Vol.51 (9), p.2758-2765

2008

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 709

Suche als RSS-Feed

Aktive Filter

ThemaBiochemistry & Molecular Biology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(497)
Mit Volltextzugriff
(471)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Pharmacological characterization of potent and selective NaV1.7 inhibitors engineered from Chilobrachys jingzhao tarantula venom peptide JzTx-V

Molecular Mechanism of Hepcidin-Mediated Ferroportin Internalization Requires Ferroportin Lysines, Not Tyrosines or JAK-STAT

Epitope Discovery for a Synthetic Polymer Nanoparticle: A New Strategy for Developing a Peptide Tag

Development of human-machine language interfaces for the visual analysis of complex biologics and RNA modalities and associated experimental data

Utilization of tyrosine- and histidine-containing dipeptides to enhance productivity and culture viability

Identification of Antibody and Small Molecule Antagonists of Ferroportin-Hepcidin Interaction

Structure-guided Discovery of Dual-recognition Chemibodies

Development of a method for the sensitive and quantitative determination of hepcidin in human serum using LC-MS/MS

Design and Chemical Synthesis of a Homogeneous Polymer-Modified Erythropoiesis Protein

Probing the S100 protein family through genomic and functional analysis

Engineering Potent and Selective Analogues of GpTx-1, a Tarantula Venom Peptide Antagonist of the NaV1.7 Sodium Channel

Engineering potent and selective analogues of GpTx-1, a tarantula venom peptide antagonist of the Na(V)1.7 sodium channel

Single Residue Substitutions That Confer Voltage-Gated Sodium Ion Channel Subtype Selectivity in the NaV1.7 Inhibitory Peptide GpTx‑1

Accelerating attribute‐focused process and product development through the development and deployment of autonomous process analytical technology platform system

Nanoscale integration of single cell biologics discovery processes using optofluidic manipulation and monitoring

Discovery of Tarantula Venom-Derived NaV1.7-Inhibitory JzTx‑V Peptide 5‑Br-Trp24 Analogue AM-6120 with Systemic Block of Histamine-Induced Pruritis

Discovery of Selective Pituitary Adenylate Cyclase 1 Receptor (PAC1R) Antagonist Peptides Potent in a Maxadilan/PACAP38-Induced Increase in Blood Flow Pharmacodynamic Model

Half-life extension of peptidic APJ agonists by N-terminal lipid conjugation

Accelerated Chemical Synthesis of Peptides and Small Proteins

Pharmaceutical Optimization of Peptide Toxins for Ion Channel Targets: Potent, Selective, and Long-Lived Antagonists of Kv1.3

Use of Cryopreserved Hepatocytes as Part of an Integrated Strategy to Characterize In Vivo Clearance for Peptide-Antibody Conjugate Inhibitors of Nav1.7 in Preclinical Species

Sustained inhibition of the NaV1.7 sodium channel by engineered dimers of the domain II binding peptide GpTx-1

Discovery of Tarantula Venom-Derived Na V 1.7-Inhibitory JzTx-V Peptide 5-Br-Trp24 Analogue AM-6120 with Systemic Block of Histamine-Induced Pruritis

Engineering Antibody Reactivity for Efficient Derivatization to Generate NaV1.7 Inhibitory GpTx‑1 Peptide–Antibody Conjugates

Design and Synthesis of Conformationally Constrained Glucagon-Like Peptide-1 Derivatives with Increased Plasma Stability and Prolonged in Vivo Activity

Aktive Filter

Suchergebnisse filtern